Institutional Ownership Protalix Bio Therapeutics, Inc. (PLX)
This table provides information about the institutional ownership of Protalix Bio Therapeutics, Inc. (PLX). We have compiled data on the 50 institutions that hold shares in the stock, with a total of 4.58 Million shares, which have been reported (via 13F filing form) to have a value of $10.9 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
1,118,000
shares
|
$2.6 Million
0.0% of portfolio
|
Q4 2024
Added 16.96%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
731,742
shares
|
$1.7 Million
0.0% of portfolio
|
Q4 2024
Added 1299.37%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
387,921
shares
|
$903,855
0.0% of portfolio
|
Q4 2024
Added 3.79%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
333,171
shares
|
$776,288
0.0% of portfolio
|
Q2 2024
Reduced 89.94%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Feb 07, 2025 Q4 2024 |
305,749
shares
|
$712,395
0.04% of portfolio
|
Q4 2024
Reduced 29.75%
|
|
|
Stratos Wealth Partners, Ltd.
|
Jan 27, 2025 Q4 2024 |
270,000
shares
|
$629,100
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Feb 14, 2025 Q4 2024 |
181,400
shares
|
$422,662
0.01% of portfolio
|
Q4 2024
Reduced 1.3%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
170,216
shares
|
$396,603
0.0% of portfolio
|
Q4 2024
Added 295.32%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
145,787
shares
|
$339,683
0.0% of portfolio
|
Q4 2024
Added 59.06%
|
|
|
Jane Street Group, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
113,616
shares
|
$264,725
0.0% of portfolio
|
Q4 2024
Added 147.25%
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
101,899
shares
|
$237,424
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Squarepoint Ops LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
73,940
shares
|
$172,280
0.0% of portfolio
|
Q4 2024
Added 33.42%
|
|
|
Orin Green Financial, LLC
|
Feb 19, 2025 Q4 2024 |
72,000
shares
|
$167,760
0.06% of portfolio
|
Q1 2024
Reduced 10.0%
|
|
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
Feb 14, 2025 Q4 2024 |
53,507
shares
|
$124,671
0.03% of portfolio
|
Q4 2024
Added 13.67%
|
|
|
Commonwealth Equity Services, LLC
|
Feb 10, 2025 Q4 2024 |
50,000
shares
|
$116,500
0.0% of portfolio
|
Q3 2024
Reduced 0.2%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
49,710
shares
|
$115,824
0.0% of portfolio
|
Q4 2024
Reduced 1.06%
|
|
|
Hsbc Holdings PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
40,023
shares
|
$93,253
0.0% of portfolio
|
Q3 2024
Reduced 15.96%
|
|
|
Prudential Financial Inc
Newark, NJ |
Feb 11, 2025 Q4 2024 |
36,400
shares
|
$84,812
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
34,323
shares
|
$79,972
0.0% of portfolio
|
Q3 2024
Reduced 3.12%
|
|
|
Virtu Financial LLC
New York, NY |
Feb 11, 2025 Q4 2024 |
34,276
shares
|
$79,863
0.0% of portfolio
|
Q4 2024
Reduced 21.0%
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
33,714
shares
|
$78,553
0.0% of portfolio
|
Q4 2024
Reduced 25.07%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Feb 14, 2025 Q4 2024 |
29,307
shares
|
$68,285
0.0% of portfolio
|
Q4 2024
Added 24.07%
|
|
|
Capital Performance Advisors LLP
|
Jan 31, 2025 Q4 2024 |
25,976
shares
|
$60,524
0.02% of portfolio
|
Q3 2024
Reduced 3.05%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
24,867
shares
|
$57,940
0.0% of portfolio
|
Q4 2024
Reduced 31.76%
|
|
|
Aptus Capital Advisors, LLC
|
Feb 14, 2025 Q4 2024 |
23,363
shares
|
$54,435
0.0% of portfolio
|
Q4 2024
Added 4.59%
|